PATH | VRL
Menu

Assessment of Immune Responses to H5N1 Inactivated Influenza Vaccine Among Individuals Previously Primed With H5N2 Live Attenuated Influenza Vaccine

This article, published in Human Vaccines & Immunotherapeutics, reports the results of a study that aimed to increase the efficacy of H5 subtype influenza vaccines. The authors found that study participants who had previously been primed with live attenuated influenza vaccine had higher immune responses when given one dose of inactivated influenza vaccine one and a half years later than those who had not been primed.

Author: Rudenko L, Naykhin A, Donina S, et al.

Published: 2015

» Visit web page (English)

(Located at www.tandfonline.com)

Citation: Rudenko L, Naykhin A, Donina S, et al. Assessment of Immune Responses to H5N1 Inactivated Influenza Vaccine Among Individuals Previously Primed With H5N2 Live Attenuated Influenza Vaccine. Human Vaccines & Immunotherapeutics. 2015;11(12):2839-2848.

Resource types: Peer-reviewed journal

Diseases/vaccines: Influenza

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Eastern Europe